ENDRA Life Sciences (NDRA) Current Leases (2019 - 2026)
ENDRA Life Sciences' (NDRA) quarterly Current Leases came in at $138644.0 in Q2 2026, up 8.13% year-over-year from $128218.0 in Q2 2025, and up 3.5% quarter-over-quarter from $133953.0 in Q1 2026.
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Current Leases (2019 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Current Leases for 8 consecutive years, with $138644.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Leases rose 8.13% year-over-year to $138644.0 in Q2 2026; TTM through Jun 2026 was $138644.0, a 8.13% increase from a year earlier, with the FY2025 full-year figure at $129378.0, up 33.47% from the prior year.
- Current Leases was $138644.0 for Q2 2026 at ENDRA Life Sciences, up from $133953.0 in the prior quarter.
- Over five years, Current Leases peaked at $187339.0 in Q3 2024 and troughed at $96937.0 in Q4 2024.
- A 5-year average of $148432.8 and a median of $144541.0 in 2022 frame the typical range for Current Leases.
- Across the five-year window, Current Leases soared 73.18% in 2022 and plunged 44.24% in 2024, its largest moves.
- Over 5 years, Current Leases stood at $152228.0 in 2022, then grew by 14.21% to $173857.0 in 2023, then sank by 44.24% to $96937.0 in 2024, then jumped by 33.47% to $129378.0 in 2025, then rose by 7.16% to $138644.0 in 2026.
- The last three Current Leases figures came in at $138644.0 (Q2 2026), $133953.0 (Q1 2026), and $129378.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | - |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | - |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | 6.78 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | - |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | 1.18 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 4.50 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - | 138,644.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 138,644.00 |
| Mar 31, 2026 | 133,953.00 |
| Dec 31, 2025 | 129,378.00 |
| Sep 30, 2025 | 128,791.00 |
| Jun 30, 2025 | 128,218.00 |
| Mar 31, 2025 | 126,097.00 |
| Dec 31, 2024 | 96,937.00 |
| Sep 30, 2024 | 187,339.00 |
| Jun 30, 2024 | 182,733.00 |
| Mar 31, 2024 | 178,239.00 |
| Dec 31, 2023 | 173,857.00 |
| Sep 30, 2023 | 168,610.00 |
| Jun 30, 2023 | 163,013.00 |
| Mar 31, 2023 | 157,554.00 |
| Dec 31, 2022 | 152,228.00 |
| Sep 30, 2022 | 147,057.00 |
| Jun 30, 2022 | 142,025.00 |
| Mar 31, 2022 | 137,117.00 |
| Dec 31, 2021 | 132,330.00 |
| Sep 30, 2021 | 127,696.00 |